REATA PHARMACEUTICALS INC Stock Price - RETA

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last: $ 90.24 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
REATA PHARMACEUTICALS INC RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  3.07 3.52% 90.24 90.38 86.68 87.54 87.17 17:14:50
Bid Price Ask Price Spread Spread % News
87.60 95.00 7.40 7.79% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,911 173,444 $ 88.90 $ 15,419,581 251,020 47.50 - 104.53
Last Trade Time Type Quantity Stock Price Currency
16:25:16 average 218 $ 90.24 USD

REATA PHARMACEUTICALS INC Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.71B 30.06M $ -80.55M -2.88 -33.67 29.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -8.48k 1.00%

more financials information »

REATA PHARMACEUTICALS INC News

Latest RETA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RETA Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week86.4690.3882.586.2183163k3.784.37%
1 Month88.3897.621982.589.8254227k1.862.10%
3 Months79.1197.621976.2588.0295225k11.1314.07%
6 Months77.15104.5373.1587.9318221k13.0916.97%
1 Year51104.5347.578.1612285k39.2476.94%
3 Years17.5104.5315.174853.0610190k72.74415.66%
5 Years11.06104.5311.0351.0598192k79.18715.91%

REATA PHARMACEUTICALS INC Description

Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways.


Your Recent History
NASDAQ
RETA
REATA PHAR..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.